KYMR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.57

Margin Of Safety %

Put/Call OI Ratio

0.7

EPS Next Q Diff

-0.41

EPS Last/This Y

0.18

EPS This/Next Y

-0.84

Price

107.49

Target Price

130.91

Analyst Recom

1.29

Performance Q

Upside

-139.2%

Beta

1.95

Ticker: KYMR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	KYMR	110.43	0.74	1.21	10143
2026-07-14	KYMR	111.93	0.75	0.47	10224
2026-07-15	KYMR	114.19	0.74	1.57	10312
2026-07-16	KYMR	113.86	0.75	0.77	10350
2026-07-17	KYMR	115.74	0.75	0.10	10413
2026-07-20	KYMR	111.09	0.67	2.63	9392
2026-07-21	KYMR	113.36	0.67	2.21	9430
2026-07-22	KYMR	110.33	0.67	0.13	9479
2026-07-23	KYMR	110.39	0.66	1.11	9650
2026-07-24	KYMR	110.51	0.67	0.00	9703
2026-07-27	KYMR	110.08	0.66	0.00	9709
2026-07-28	KYMR	106.08	0.66	1.18	9723
2026-07-29	KYMR	105.38	0.67	0.11	9824
2026-07-30	KYMR	106.99	0.67	35.00	9832
2026-07-31	KYMR	103.31	0.67	0.47	9884
2026-08-03	KYMR	100.17	0.67	15.80	9891
2026-08-04	KYMR	104.59	0.69	1.39	9968
2026-08-05	KYMR	105.48	0.69	0.15	9999
2026-08-06	KYMR	106.41	0.70	0.00	9926
2026-08-07	KYMR	107.62	0.70	1.40	9927
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	KYMR	110.51	21.7	-	-3.52
2026-07-14	KYMR	112.02	21.7	-	-3.52
2026-07-15	KYMR	114.23	21.7	-	-3.51
2026-07-16	KYMR	113.93	21.7	-	-3.51
2026-07-17	KYMR	115.74	21.7	-	-3.51
2026-07-20	KYMR	111.11	21.7	-	-3.51
2026-07-21	KYMR	113.36	21.7	-	-3.51
2026-07-22	KYMR	110.34	21.7	-	-3.51
2026-07-23	KYMR	110.36	21.7	-	-3.51
2026-07-24	KYMR	110.53	21.7	-	-3.51
2026-07-27	KYMR	110.10	21.7	-	-3.51
2026-07-28	KYMR	106.11	21.7	-	-3.51
2026-07-29	KYMR	105.28	21.7	-	-3.51
2026-07-30	KYMR	106.81	21.7	-	-3.51
2026-07-31	KYMR	103.34	21.7	-	-3.51
2026-08-03	KYMR	100.23	21.7	-	-3.51
2026-08-04	KYMR	100.23	21.7	-	-3.51
2026-08-05	KYMR	105.43	22.3	-	-3.51
2026-08-06	KYMR	106.37	22.3	-	-3.51
2026-08-07	KYMR	107.49	-9.4	-	-3.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	KYMR	-30.08	4.04	13.90
2026-07-14	KYMR	-30.08	4.04	13.90
2026-07-15	KYMR	-30.08	4.04	13.90
2026-07-16	KYMR	-30.08	4.04	13.90
2026-07-17	KYMR	-30.08	4.04	13.90
2026-07-20	KYMR	-30.08	3.31	13.90
2026-07-21	KYMR	-30.11	3.31	13.90
2026-07-22	KYMR	-30.11	3.31	13.90
2026-07-23	KYMR	-30.11	3.31	13.90
2026-07-24	KYMR	-30.11	3.31	13.90
2026-07-27	KYMR	-30.11	3.42	13.56
2026-07-28	KYMR	-30.11	3.42	13.56
2026-07-29	KYMR	-30.11	3.42	13.56
2026-07-30	KYMR	-30.11	3.42	13.56
2026-07-31	KYMR	-30.11	3.42	13.56
2026-08-03	KYMR	-30.11	3.07	13.56
2026-08-04	KYMR	-30.11	3.07	13.57
2026-08-06	KYMR	-30.02	3.07	13.57
2026-08-07	KYMR	-30.02	3.07	13.57
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.62

Avg. EPS Est. Current Quarter

-1.03

Avg. EPS Est. Next Quarter

-1.03

Insider Transactions

-30.02

Institutional Transactions

3.07

Beta

1.95

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

17.3

Max Drawdown 5-Year %

-83.5

Target Price

130.91

P/E

Forward P/E

PEG

P/S

85.15

P/B

5.9

P/Free Cash Flow

EPS

-3.24

Average EPS Est. Cur. Y

-3.51

EPS Next Y. (Est.)

-4.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-285.34

Relative Volume

0.58

Return on Equity vs Sector %

-47.2

Return on Equity vs Industry %

-31.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ KYMR Healthcare

$107.52

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

17/25

Volume

11/15

Valuation

7/20

TP/AR

2/10

Options

4/10

RSI

51.9

Range 1M

34.7%

Sup Dist

3.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

9/30

Estimates

0/20

Inst/Vol

4/15

Options

3/10

EPS Yr

-1.8%

52W%

75.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +21.8% upside

Quality

6/30

Valuation

6/30

Growth

4/25

Stability

8/10

LT Trend

3/5

Upside

+21.8%

Quality

KYMR — P/E HistoricalBiotechnology

Kymera Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 273

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing KT-621, an oral STAT6 degrader in Phase 2b clinical trials for moderate to severe atopic dermatitis, asthma, COPD, EoE, CRSwNP, CSU, PN, BP, and others; KT-579, an oral IRF5 degrader in Phase 1 trials for autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, SSc, DM, and others; KT-485/SAR447971, IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis; and cyclin-dependent kinase 2 (CDK2) with broad oncology treatment potential, including in breast cancer and other solid tumors. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

KYMR

Latest News

—

Caricamento notizie per KYMR…

stock quote shares KYMR – Kymera Therapeutics, Inc. Stock Price stock today

news today KYMR – Kymera Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KYMR – Kymera Therapeutics, Inc. yahoo finance google finance

stock history KYMR – Kymera Therapeutics, Inc. invest stock market

stock prices KYMR premarket after hours

ticker KYMR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KYMR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y